Shares of Heska Corp. (NASDAQ:HSKA) have been given a consensus rating of “Buy” by the six ratings firms that are currently covering the firm. Three analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $51.00.

A number of brokerages have recently issued reports on HSKA. B. Riley downgraded shares of Heska Corp. from a “buy” rating to a “neutral” rating and increased their price target for the stock from $52.50 to $53.00 in a report on Wednesday, September 21st. Zacks Investment Research downgraded shares of Heska Corp. from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 5th. Gabelli downgraded shares of Heska Corp. from a “buy” rating to a “hold” rating in a report on Thursday, August 4th. Finally, Sidoti assumed coverage on shares of Heska Corp. in a report on Friday, July 1st. They issued a “buy” rating and a $49.00 price target on the stock.

In other Heska Corp. news, EVP Steve Asakowicz sold 4,698 shares of Heska Corp. stock in a transaction that occurred on Tuesday, August 9th. The shares were sold at an average price of $52.55, for a total transaction of $246,879.90. Following the transaction, the executive vice president now directly owns 12,858 shares of the company’s stock, valued at $675,687.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Kevin S. Wilson sold 5,465 shares of Heska Corp. stock in a transaction that occurred on Monday, July 18th. The stock was sold at an average price of $44.31, for a total transaction of $242,154.15. Following the transaction, the chief executive officer now directly owns 144,535 shares in the company, valued at $6,404,345.85. The disclosure for this sale can be found here. 15.30% of the stock is currently owned by corporate insiders.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Bank of Montreal Can acquired a new position in Heska Corp. during the second quarter valued at approximately $128,000. Acrospire Investment Management LLC increased its position in Heska Corp. by 786.3% in the second quarter. Acrospire Investment Management LLC now owns 4,396 shares of the company’s stock valued at $163,000 after buying an additional 3,900 shares during the period. Metropolitan Life Insurance Co. NY increased its position in Heska Corp. by 7.1% in the second quarter. Metropolitan Life Insurance Co. NY now owns 4,853 shares of the company’s stock valued at $180,000 after buying an additional 320 shares during the period. BlackRock Inc. increased its position in Heska Corp. by 863.1% in the second quarter. BlackRock Inc. now owns 5,095 shares of the company’s stock valued at $189,000 after buying an additional 4,566 shares during the period. Finally, Rhumbline Advisers acquired a new position in Heska Corp. during the second quarter valued at approximately $222,000. 68.32% of the stock is currently owned by hedge funds and other institutional investors.

Heska Corp. (NASDAQ:HSKA) traded up 0.34% during midday trading on Wednesday, hitting $53.62. 30,485 shares of the stock were exchanged. The company’s 50 day moving average is $54.09 and its 200-day moving average is $41.77. The stock has a market cap of $368.64 million, a PE ratio of 54.33 and a beta of 0.41. Heska Corp. has a 1-year low of $26.26 and a 1-year high of $57.41.

Heska Corp. (NASDAQ:HSKA) last announced its quarterly earnings results on Wednesday, August 3rd. The company reported $0.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.17. Heska Corp. had a net margin of 6.22% and a return on equity of 8.75%. The firm had revenue of $30 million for the quarter, compared to the consensus estimate of $28.47 million. The firm’s revenue was up 25.5% on a year-over-year basis. On average, analysts expect that Heska Corp. will post $1.12 earnings per share for the current year.

About Heska Corp.

Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals.

5 Day Chart for NASDAQ:HSKA

Receive News & Stock Ratings for Heska Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska Corp. and related stocks with our FREE daily email newsletter.